These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of gene therapies for cardiovascular and renal diseases by nucleic acid medicines. Fukuda N Med Chem; 2006 Jan; 2(1):13-9. PubMed ID: 16787351 [TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus as a model vector system for gene therapy in renal disease. Herold BC; Marcellino D; Marcelin G; Wilson P; Burrow C; Satlin LM Kidney Int; 2002 Jan; 61(1 Suppl):S3-8. PubMed ID: 11841605 [TBL] [Abstract][Full Text] [Related]
4. [Development of nucleic acid transfection technology to the kidney]. Mukai H; Kawakami S; Hashida M Yakugaku Zasshi; 2008 Nov; 128(11):1577-86. PubMed ID: 18981692 [TBL] [Abstract][Full Text] [Related]
5. Applications of gene therapy to kidney disease. Hanss B; Bruggeman LA Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):439-45. PubMed ID: 12815341 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic antisense and ribozymes. Rossi JJ Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta as a treatment target in renal diseases. Fukuda N; Tahira Y; Matsuda H; Matsumoto K J Nephrol; 2009; 22(6):708-15. PubMed ID: 19967649 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy: how to target the kidney. Promises and pitfalls. Tomasoni S; Benigni A Curr Gene Ther; 2004 Mar; 4(1):115-22. PubMed ID: 15032618 [TBL] [Abstract][Full Text] [Related]
10. Gene transfer into the adult kidney for unravelling disease processes. Kitamura M; Fine LG Exp Nephrol; 1998; 6(5):429-37. PubMed ID: 9730659 [TBL] [Abstract][Full Text] [Related]
11. Towards gene therapy for renal diseases. Imai E; Akagi Y; Isaka Y Nephrologie; 1998; 19(7):397-402. PubMed ID: 9857374 [TBL] [Abstract][Full Text] [Related]
12. Antisense approaches to cancer gene therapy. Mercola D; Cohen JS Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254 [TBL] [Abstract][Full Text] [Related]
13. The potential application of ribozymes for the treatment of hematological disorders. James HA J Leukoc Biol; 1999 Sep; 66(3):361-8. PubMed ID: 10496304 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy in renal diseases. Imai E; Takabatake Y; Mizui M; Isaka Y Kidney Int; 2004 May; 65(5):1551-5. PubMed ID: 15086890 [TBL] [Abstract][Full Text] [Related]
16. Genetics and Gene Therapy of Anderson-Fabry Disease. Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309 [TBL] [Abstract][Full Text] [Related]
17. Renal diseases as targets of gene therapy. Phillips B; Giannoukakis N; Trucco M Contrib Nephrol; 2008; 159():1-12. PubMed ID: 18391581 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy for renal disorders: what are the benefits for the elderly? Lien YH; Lai LW Drugs Aging; 2002; 19(8):553-60. PubMed ID: 12207549 [TBL] [Abstract][Full Text] [Related]
19. Liver as a target for oligonucleotide therapeutics. Sehgal A; Vaishnaw A; Fitzgerald K J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039 [TBL] [Abstract][Full Text] [Related]
20. Chronic deteriorating renal function and renal fibrosis. Isaka Y; Takahara S; Imai E Contrib Nephrol; 2008; 159():109-121. PubMed ID: 18391588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]